thomas mcnerney  partners home profile team companies news contact professionals james thomas alex zisson eric aguiar md kathleen tune jason brown phd susan haedt kristi lacroix jason m brown phd partnerjason joined thomas mcnerney  partners in  after spending four years as a member of the investment team at forward ventures where he played an active role in forwardled rounds of investment totaling over  million prior to joining forward jason conducted research in antimicrobial drug discovery and bacterial genomics as a postdoctoral fellow in infectious diseases at johnson  johnson pharmaceutical research and development he is currently a board member of  tioga pharmaceuticals inc jason earned a phd in biology at the university of california san diego where he was a national science foundation fellow and a bs in molecular biology and biochemistry from purdue university âš  thomas mcnerney  partners  all rights reserved thomas mcnerney  partners   home profile team companies news contact ethicon announces agreement to acquire torax medical inc                                                                                                    partners group to acquire pci pharma services a leading global provider of oursourced pharmaceutical services                                                                                                    jazz pharmaceuticals and celator pharmaceuticals announce agreement for jazz pharmaceuticals to acquire celator for  per share                                                                                               thomas mcnerney  partners is a health care venture firm that invests in life science and medical technology companies at all stages of development the thomas mcnerney  partners team has significant experience in helping entrepreneurs start companies in providing growth capital to emerging companies and in undertaking restructuring transactions such as spinouts rollups and recapitalizations imagesfinalswf imagesfinalswf â  thomas mcnerney  partners  all rights reserved  site by impend thomas mcnerney  partners home profile team companies news contact professionals james thomas alex zisson eric aguiar md kathleen tune jason brown phd susan haedt kristi lacroix richard d dimarchi phd endocrinology  drug development dr dimarchi is the linda  jack gill chair in biomolecular sciences and professor of chemistry at indiana university he is a retired group vice president for biotechnology and product development at eli lilly  company where for more than two decades he provided leadership in biotechnology endocrine research and product development professor dimarchi is recognized for the discovery and development of rdnaderived humalog® lisprohuman insulin this designer insulin represents the first demonstration that structurally altered rdnaderived biosynthetic proteins can improve pharmacological performance without increasing the risk of an abnormal immunological response as scientist and administrator at lilly dr dimarchi participated in the commercial development of humulin® humatrope® xigris® and forteo® the goal of his current research and commercial endeavors is to develop proteins with enhanced therapeutic properties through biochemical optimization with nonnatural amino acids an approach he has termed chemicalbiotechnology dr dimarchi received his phd from indiana university   thomas mcnerney  partners  all rights reserved thomas mcnerney  partners home profile team companies news contact professionals james thomas alex zisson pratik shah phd eric aguiar md kathleen tune jason brown phd susan haedt advisors bruce chabner md richard dimarchi phd gerald fischbach md robert schwartz md jay short phd bruce a chabner md oncologydr chabner is a professor of medicine at harvard medical school clinical director of the cancer center at massachusetts general hospital with the formation of the danafarberharvard cancer center he also has responsibilities as associate director for clinical sciences of that consortium which includes the massachusetts general hospital brigham  womens hospital danafarber cancer institute and beth israel deaconess medical center dr chabner was previously at the national cancer institute nci where he participated in the training of clinical and research fellows for  years and served for  years as permanent director of the division of cancer treatment nci from  to  he maintained an active laboratory program in cancer pharmacology at the nci focusing on the mechanism of action and resistance of antifolates and other antimetabolites and leading the development of paclitaxel taxolâž his research has contributed significantly to the development of high dose chemotherapy regimens and to standard therapies for lymphoma he received an md cum laude from harvard medical school âš  thomas mcnerney  partners  all rights reserved thomas mcnerney  partners home profile team companies news contact professionals james thomas alex zisson pratik shah phd eric aguiar md kathleen tune jason brown phd susan haedt kristi lacroix pratik shah phd partnerpratik joined thomas mcnerney  partners in  and represents thomas mcnerney  partners on the boards of cebix incorporated and sgb inc he was also a board member at cns therapeutics inc prior to its acquisition in  and ocera therapeutics inc ocrx  prior to joining the firm he was the chief business officer and cofounder of kalypsys inc a biopharmaceutical company focused on the discovery and clinical development of new medicines for cancer inflammation and metabolic disease using its proprietary automation technologies before cofounding kalypsys pratik was at mckinsey  company where he focused on biotechnology and venture capital projects he was formerly a cofounder and vp of operations at nephrx corporation a startup company focused on the discovery of therapeutic proteins for renal disease pratik holds a bs in biological sciences from the university of california at irvine and both a phd in biochemistry  molecular biology and an mba from the university of chicago âš  thomas mcnerney  partners  all rights reserved thomas mcnerney  partners recent newsarchivevertiflex® home profile team companies news contact recent news archive ethicon announces agreement to acquire torax medical inc                                             february   partners group to acquire pci pharma services a leading global provider of outsourced pharmaceutical services                                                                                                         june   jazz pharmaceuticals and celator pharmaceuticals announce agreement for jazz pharmaceuticals to acquire celator for  per share                                                         may                                                     btg plc acquires galil medical a leader in cryoablation                                                           may   celator announces phase  trial for vyxeos cpx in patients with high risk acute myeloid leukemia demonstrates statistically significant improvement in overall survival march   icalamerican medical association creates new category  code for torax medicals linx procedure to treat gastroesophageal reflux disease                                                               november   vertiflex® announces two significant reimbursement milestones to expand market opportunity for superion interspinous spacer vertiflex®                                                     november   celator r pharmaceuticals announces positive induction response results from phase  study of cpx in patients with highrisk secondary acute  myeloid leukemia june   tioga pharmnaceuticals announces initiation of phase  clinical study of asimadoline in patients with pruritus associated with atopic dermatitis june   vertiflexr inc announces fda pma approval for the superionr interspinous spacer may   teva reinforces leadership position in cns with acquisition of auspex march   boston scientific receives fda approval for watchman tm left atrial appendage closure device march   vertiflexr inc announces fda advisory panel support for the superionr interspinous spacer february   invitae announces pricing of initial public offering of common stock february   cas medical systems announces pricing of public offering of common stock february   auspex pharmaceuticals completes enrollment in a pivotal clinical trial of  in tardive dyskinesia february   auspex announces pricing of follow on offering january   celatorr pharmaceuticals receives fda fast track designation for cpx for the treatment of elderly patients with secondary acute myeloid leukemia january   auspex pharmaceuticals receives fda orphan drug designation of sd for treatment of tourette syndrome in the pediatric population january   auspex pharmaceuticals announces sd program for the potential treatment of parkinsons disease and related movement disorders january   casmed appoints paul molloy to its board of directors january   auspex announces topline results from registration trial of sd for chorea associated with huntingtons disease december   auspex pharmaceuticals receives fda orphan drug designation of sd for treatment of huntingtons disease november   celatorr pharmaceuticals announces phase  clinical study of cpx achieved target enrollment in high risk secondary acute myeloid leukemia october   invitae completes  million series f financing october   pfizer completes acquisition of innopharma september   pci announces definitive agreement to acquire penn pharma july   clarus therapeutics expands board of directors with appointment of two pharmaceutical industry veterans july   auspex pharmaceuticals initiates pivotal phase  clinical trial for sd in tardive dyskinesia july   pfizer to acquire innopharma inc july   auspex pharmaceuticals announces data from interim analysis of archd switch trial demonstrating clinical activity of sd june   clarus therapeutics secures  million in financing june   celatorr pharmaceuticals announces publication of positive phase  data with cpx in acute myeloid leukemia patients  may   casmed receives fda approval for foresite elite in noncerebral tissue may   auspex pharmaceuticals added to the russell ® index march   auspex announces completion of public offering and exercise in full of underwriters overallotment option february   auspex announces pricing of initial public offering february   vertiflexr inc announces decision by the centers for medicare  medicaid services january   clarus therapeutics submits new drug application for rextoro formerly clr for the treatment of low testosterone  january   celatorr pharmaceuticals reaches  enrollment for cpx phase  study  january   auspex raises  million and appoints industry veteran gerald proehl to its board of directors january     thomas mcnerney  partners  all rights reserved thomas mcnerney  partners home profile team companies news contact professionals james thomas alex zisson pratik shah phd eric aguiar md kathleen tune pete mcnerney jason brown phd susan haedt advisors bruce chabner md richard dimarchi phd gerald fischbach md robert schwartz md jay short phd peter h mcnerney senior advisorpete has over  years of health care operating and venture capital experience in addition to cofounding thomas mcnerney  partners pete cofounded coral ventures in  where he was responsible for health care investing pete has served on the board of a number of the coral ventures and thomas mcnerney and partners portfolio companies prior to joining coral in  pete was a cofounder and managing partner of the kensington group a firm specializing in providing management services to early stage companies in the health care field in  he founded and was chief executive officer of memtec north america a company established to commercialize cross flow membrane microfiltration technology in north america previously pete spent  years with baxter healthcare corporation where he held various general management positions in the us europe middle east and southeast asia he has served as president of the minnesota venture capital association and is on the board of trustees of blue cross and blue shield of minnesota a certified public accountant pete received a ba from yale and an mba from stanford university  pete was a  fellow at harvards advanced leadership initiative program âš  thomas mcnerney  partners  all rights reserved insider trading  thomas mcnerney  partners ii llc  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  thomas mcnerney  partners ii llc select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchase  pm cas medical systems inc casm thomas mcnerney  partners ii lpthomas mcnerney  partners ii llctmp nominee ii llctmp associates ii lp owner    directindirect view sale  pm auspex pharmaceuticals inc aspx thomas mcnerney  partners ii llcthomas mcnerney  partners ii lptmp associates ii lptmp nominee ii llcdirector owner    indirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing equity swap  am nana auspex pharmaceuticals inc aspx thomas mcnerney  partners ii llcthomas mcnerney  partners ii lptmp associates ii lptmp nominee ii llcdirector owner   indirect view conversion  pm nana invitae corp nvta aguiar ericthomas mcnerney  partners ii lptmp associates ii lptmp nominee ii llcthomas mcnerney  partners ii llcdirector owner   indirect view conversion  pm nana invitae corp nvta aguiar ericthomas mcnerney  partners ii lptmp associates ii lptmp nominee ii llcthomas mcnerney  partners ii llcdirector owner   indirect view conversion  pm nana invitae corp nvta aguiar ericthomas mcnerney  partners ii lptmp associates ii lptmp nominee ii llcthomas mcnerney  partners ii llcdirector owner   indirect view conversion  pm nana invitae corp nvta aguiar ericthomas mcnerney  partners ii lptmp associates ii lptmp nominee ii llcthomas mcnerney  partners ii llcdirector owner   indirect view conversion  pm nana invitae corp nvta aguiar ericthomas mcnerney  partners ii lptmp associates ii lptmp nominee ii llcthomas mcnerney  partners ii llcdirector owner   indirect view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  thomas mcnerney  partners llc  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors thomas mcnerney  partners llc check out list of companies and businesses related to thomas mcnerney  partners llc find out thomas mcnerney  partners llc address and contact details view other people related to thomas mcnerney  partners llc  coworkers colleagues companions etc address  south th street suite  minneapolis  mn companies related to thomas mcnerney  partners llc cikcompany namepositioncompany addressocera therapeutics inc twin dolphin drive suite  redwood city coley pharmaceutical group inc worcester st suite  wellesley zogenix inc horton street  emeryville  thomas mcnerney  partners llc on the web persons related to thomas mcnerney  partners llc  ocera therapeutics incnamepositioncity capital gp llc owner new yorkdavidson aarondurhamgeorge b abercrombiedirector durhamgeorge b abercrombiedirector durhamgaurav aggarwalchief business officer south san franciscogaurav aggarwalchief business officer palo altoeric aguiarstamforderic aguiarminneapoliszisson alexdurhamvanlent annesan diegovanlent annepalo altoalain azanmenlo parkbaker biotech capital gp llc owner new yorkbaker brothers life sciences capital gp llc owner new yorkfelix bakernew yorkjulian bakernew yorkbdc capital inc owner montreal quebec canadajames c blair owner princetongavin brendadurhameric buatoismenlo parkstan bukofzerchief medical officer palo altomichael byrnescfo and treasurer palo altoregional et cooperatif desjardins capital owner montreal quebec canadajeanpaul castaignedirector durhamjeanpaul castaignedirector durhamjeanpaul castaignedirector palo altomcgowan danasan diegodrutz daviddurhammoore davidsan diegomoore davidpalo altoaaron davidsondirector durhamaaron davidsonmiamiaaron davidsondirector durhamwillard h deredirector thousand oakssec desjardinsinnovatechmontreal quebec canadaassociates domainprincetondomain partners vi lp owner princetondomain partners viii lpprincetoncorcoran donalddurhambrian h dovey owner princetondp vi associates lpprincetondp viii associates lpprincetonweber eckardpalo altoweber eckardsan diegorichard i eisenstadtvp finance  cfo durhamrichard i eisenstadtvp finance  cfo durhamlars ekmanla jollarousseau francksan diegorousseau franckpalo altovipin k gargpresident  ceo durhamvipin k gargpresident  ceo durhambrenda d gavinphiladelphiabrenda d gavindirector durhamlinda s graispresident and ceo menlo parklinda s graispresident and ceo san diegolinda s graispresident and ceo palo altohig ventures  tranzyme llc owner miamibrian k halak owner princetonjames healymenlo parkhig gp ii incmiamijeryl l hillemansan diegojeryl l hillemancfo and secretary palo altosteven p jamesdirector steven p jamesdirector palo altocastaigne jeanpauldurhamcastaigne jeanpaulsan diegocastaigne jeanpaulpalo altohilleman jerylpalo altojohn johnsondirector durhamjohn johnsondirector durhamkim p kamdarprincetonnina s kjellsondirector menlo parknina s kjellsondirector palo altonina s kjellsondirector menlo parknina s kjellsondirector menlo parkgordana kosuticvp clinical and regulatory durhamekman larssan diegoekman larspalo altograis lindasan diegograis lindapalo altodana s mcgowancfo and secretary san diegopete mcnerneyminneapolispete mcnerneyminneapolispowell michaelsan diegopowell michaelpalo altosami mnaymnehmiamidavid moorevp commercial operations durhamdavid moorevp commercial operations durhamkjellson ninasan diegokjellson ninapalo altorajiv patnichief development officer palo altomichael powelldirector michael powelldirector menlo parkmichael powelldirector palo altoshah pratiksan diegoshah pratikpalo altoquaker bio ventures lp owner philadelphiaquaker bioventures capital lpphiladelphiaeisenstadt richarddurhamfranck rousseauchief medical officer durhamfranck rousseauchief medical officer durhamfranck rousseauchief medical  dev officer palo altokathleen k schoemaker owner princetonnimesh shahprincetonpratik shahminneapolispratik shahminneapolispratik shahdirector palo altosofinnova management vi llcmenlo parksofinnova venture affiliates vi lpmenlo parksofinnova venture partners vi gmbh  co kgmenlo parksofinnova venture partners vi l p owner menlo parkrhonda l stanleydurhamanthony tamermiamisharon tetlowacting cfo  treasurer palo altohelmut thomassenior vp rd durhamhelmut thomassenior vp rd durhamjames e thomasjames e thomasminneapolisjames e thomasminneapolisjames e thomasminneapolisthomas mcnerney  partners ii lpminneapolisthomas mcnerney  partners ii lpminneapolisthomas mcnerney  partners ii lpminneapolisthomas mcnerney  partners ii llcminneapolisthomas mcnerney  partners ii llcminneapolisthomas mcnerney  partners lpminneapolisthomas mcnerney  partners lp owner minneapolisthomas mcnerney  partners lpminneapolistmp associates ii lpminneapolistmp associates ii lpminneapolistmp associates ii lpminneapolistmp associates lpminneapolistmp associates lpminneapolistmp associates lpminneapolistmp nominee ii llcminneapolistmp nominee ii llcminneapolistmp nominee llcminneapolistmp nominee llcminneapolistmp nominee llcminneapolisjesse i treu owner princetonanne vanlentdirector princetonanne vanlentdurhamanne vanlentdirector durhamanne vanlentdirector durhamanne vanlentdirector palo altogarg vipindurhamnicole vitullo owner princetoneckard weberdirector south san franciscoeckard webersan diegoeckard weberdirector san diegoeckard weberdirector palo altowendall wierengadirector palo altowendall d wierengadirector san diegoalex zissonminneapolisalex zissondirector durhamalex zissondirector durhamalex zissonminneapolispersons related to thomas mcnerney  partners llc  coley pharmaceutical group incnamepositioncitycharles h abdalian jrsvp finance and cfo wellesleycharles h abdalian jrsvp finance  cfo wellesleykenneth batedirector wellesleykenneth batedirector wellesleysteven b bernitzwellesleyrobert l bratzlerpresident and ceo wellesleygert caspritzdirector wellesleyanthony b evnindirector new yorkrobert j hugindirector wellesleyrobert j hugindirector wellesleymanfred e karobathdirector wellesleymanfred e karobathdirector wellesleyarthur m kriegsvp r  d chief scien off wellesleypatrick langloisdirector wellesleypatrick langloisdirector wellesleyferdinand e massarisr vp of drug development wellesleyferdinand e massarisvp drug dev  cmo wellesleypfizer incnew yorkjames e thomasstamfordjames e thomasdirector stamfordjames e thomasdirector stamfordjames e thomasdirector stanfordthomas mcnerney  partners lpminneapolisthomas mcnerney  partners lp owner minneapolistmp associates lpminneapolistmp associates lpminneapolistmp nominee llcminneapolislimited partnership tvm iii owner bostontvm iv gmbh  co kg owner bostontvm iv management gmbh  co kgbostontvm medical ventures gmbh  co kg owner bostontechno venture management gmbh tvmbostontechno venture management no limited partnership tvm iiibostontvm v life science ventures gmbh  co kg owner bostontvm v life science ventures management gmbh  co kgbostonvef management iii llc owner new yorkassociates venrock owner new yorkvenrock associates iii lp owner new yorkvenrock entrepreneurs fund iii lp owner new yorkvenrock management iii llc owner new yorkpersons related to thomas mcnerney  partners llc  zogenix incnamepositioncityzisson alexminneapolisrhoads annsan diegominocherhomjee ardachicagominocherhomjee phd ardasan diegojames c blairdirector princetonlouis c bockdirector foster citylouis c bockdirector foster citylouis c bockdirector foster cityjames b breitmeyerdirector san diegojames b breitmeyerdirector san diegomark j brooksfoster citygarner camsan diegogarner camsan diegochicago growth management ii llcchicagochicago growth management ii llcchicagochicago growth management ii llcchicagochicago growth management ii lpchicagochicago growth management ii lpchicagochicago growth partners ii l pchicagochicago growth partners ii l p chicagoclarus lifesciences i lp owner cambridgeclarus lifesciences i lp owner cambridgeclarus ventures i llccambridgeclarus ventures i llccambridgeclarus ventures i management lpcambridgeclarus ventures i management lpcambridgerobinson cynthiasan diegothierry jp darcisevp  general manager europe san diegonassif davidsan diegoassociates domainprincetondomain parters vii l p owner princetondomain partners vi lpprincetondomain partners vi lp owner princetonbrian h dovey owner princetondp vi associates lp owner princetondp vii associates lp owner princetonjoseph edelmanmast erlesan diegomast erlesan diegogail m farfelevpchief development officer new havenstephen j farrpresident and ceo haywardstephen j farrsan diegostephen j farrpresident and coo san diegostephen j farrpresident and coo san diegonicholas galakatoscambridgenicholas galakatoscambridgebradley s galerevpchief medical officer san diegocam l garnerdirector carlsbadcam l garnerdirector san diegocam l garnerdirector san diegoken haasdirector menlo parkbrian k halak owner princetonroger hawleydirector brisbaneroger hawleychief executive officer san diegoroger hawleychief executive officer san diegodennis hennercambridgedennis hennercambridgehaldeman jdsan diegoblair jamesprincetonkim p kamdarprincetonhaas kensan diegohaas kenmenlo parkwheeler kurtcambridgerobert liptakcambridgerobert liptakcambridgebock louisfoster cityerle t mastdirector bouldererle t mastdirector san diegoerle t mastsan diegoerle t mastdirector san diegopete mcnerneyminneapolisarda phd minocherhomjeedirector chicagoarda phd minocherhomjeechicagokate mitchellfoster cityrory odriscollfoster cityperceptive advisors llcwashingtonperceptive life sciences master fund ltdwashingtonann d rhoadsevp cfo treasurer  sec san joseann d rhoadsevp cfo treasurer  sec san diegoann d rhoadsevp cfo treasurer  sec san diegocynthia y robinsonchief development officer san diegocynthia y robinsonchief development officer san diegohawley rogersan diegoscale venture management ii llcfoster cityscale venture partners ii lp owner foster citykathleen k schoemaker owner princetonrichard scott shivelychief commercial officer san diegonicholas simoncambridgenicholas simoncambridgemichael p smithevp cfo treasurer  sec vancouvermichael steinmetzcambridgemichael steinmetzcambridgefarr stephensan diegorenee p tannenbaumdirector san diegojames e thomasminneapolisthomas mcnerney  partners ii lpminneapolisthomas mcnerney  partners ii llcminneapolisthomas mcnerney  partners lp minneapolistmp associates ii lpminneapolistmp associates lpminneapolistmp nominee ii llcminneapolistmp nominee llcminneapolisjesse i treu owner princetonnicole vitullo owner princetonkurt wheelerdirector cambridgekurt wheelerdirector cambridgesharon l wienbarfoster citymark c wigginsdirector san diegomark c wigginsdirector san diegomark c wigginsdirector san diego potentially same personnamecitycountrythomas mcnerney  partners llcminneapolismnthomas mcnerney  partners llcminneapolismnthomas mcnerney  partners llcminneapolismn james e thomas msc executive profile  biography  bloomberg july    pm et capital markets company overview of thomas mcnerney  partners snapshotpeople  overviewboard memberscommittees executive profile james e thomas mscpartner thomas mcnerney  partnersagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr james e thomas msc is a partner at thomas mcnerney  partners mr thomas cofounded mcnerney  partners he served as a managing partner of thomas mcnerney  partners llc since march  from  to june  he served in various capacities including from january  to  as a partner and managing director at em warburg pincus  co llc he served as a director of operations at universata inc he served as the managing director of warburg pincus  llc he also headed warburg pincus llc’s medical technology private equity practice where he had responsibility for a team of four professionals making investments in biotechnology pharmaceutical medical device and diagnostic companies he had a year tenure at warburg prior to joining warburg he served as the vice president at goldman sachs international in from  to  mr thomas has been a director of medtronic xomed surgical products inc formerly xomed surgical products inc since april  he serves as a member of the board of directors at the keystone dental inc  second stage theatre and the childrens hospital he has been director since november  and served as the chairman at celtrix pharmaceuticals inc since april  he has been a director of cas medical systems inc since june   and serves as its lead director since april  he served as a director of galil medical ltd he was a director of torax medical inc since september   and clarus therapeutics inc since february  mr thomas served as a director at wright medical group inc since august  until director  he served as director at wright medical group inc from december  to march  he served as director at wright medical technology inc coley pharmaceutical group inc innopharma inc and osteobiologics inc he served as the chairman at solstice neurosciences inc until october  he served as a director at the medicines company from september  to february   and medtronic xomed inc since april  mr thomas served as a director at transkaryotic therapies inc since may  and anergen incorporated since april  he served as director of shire human genetic therapies inc since may  he served as a director at menley  james inc since  he served as a director of oxford gycosciences plc solstice neurosciences inc oxford glycosciences plc vertiflex inc and neocrin company he served as a director of scientific learning corp he has been investing in health care companies since  mr thomas received an msc in economics from the london school of economics and graduated magna cum laude with a babs in finance and economics from the wharton school from the university of pennsylvaniaread full background corporate headquarters one stamford plazastamford connecticut united statesphone fax  board members memberships presentlead directorcas medical systems inc education ba university of pennsylvania  the wharton schoolbs university of pennsylvania  the wharton schoolms the london school of economics and political science other affiliations warburg pincus llcanergen incorporatedceltrix pharmaceuticals inccoley pharmaceutical group incmenley  james incmedtronic xomed incneocrin companyoxford glycosciences plcscientific learning corporationthe medicines companyshire human genetic therapies incwright medical group nvgalil medical ltdosteobiologics inccas medical systems incgoldman sachs internationalwarburg pincus ventures lpthomas mcnerney  partners lpuniversity of pennsylvania  the wharton schoolwright medical technology incthe london school of economics and political scienceclarus therapeutics inctorax medical incsolstice neurosciences llcvertiflex incuniversata incthomas mcnerney  partners ii lpinnopharma inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact thomas mcnerney  partners please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close james e thomas msc executive profile  biography  bloomberg july    pm et capital markets company overview of thomas mcnerney  partners snapshotpeople  overviewboard memberscommittees executive profile james e thomas mscpartner thomas mcnerney  partnersagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr james e thomas msc is a partner at thomas mcnerney  partners mr thomas cofounded mcnerney  partners he served as a managing partner of thomas mcnerney  partners llc since march  from  to june  he served in various capacities including from january  to  as a partner and managing director at em warburg pincus  co llc he served as a director of operations at universata inc he served as the managing director of warburg pincus  llc he also headed warburg pincus llc’s medical technology private equity practice where he had responsibility for a team of four professionals making investments in biotechnology pharmaceutical medical device and diagnostic companies he had a year tenure at warburg prior to joining warburg he served as the vice president at goldman sachs international in from  to  mr thomas has been a director of medtronic xomed surgical products inc formerly xomed surgical products inc since april  he serves as a member of the board of directors at the keystone dental inc  second stage theatre and the childrens hospital he has been director since november  and served as the chairman at celtrix pharmaceuticals inc since april  he has been a director of cas medical systems inc since june   and serves as its lead director since april  he served as a director of galil medical ltd he was a director of torax medical inc since september   and clarus therapeutics inc since february  mr thomas served as a director at wright medical group inc since august  until director  he served as director at wright medical group inc from december  to march  he served as director at wright medical technology inc coley pharmaceutical group inc innopharma inc and osteobiologics inc he served as the chairman at solstice neurosciences inc until october  he served as a director at the medicines company from september  to february   and medtronic xomed inc since april  mr thomas served as a director at transkaryotic therapies inc since may  and anergen incorporated since april  he served as director of shire human genetic therapies inc since may  he served as a director at menley  james inc since  he served as a director of oxford gycosciences plc solstice neurosciences inc oxford glycosciences plc vertiflex inc and neocrin company he served as a director of scientific learning corp he has been investing in health care companies since  mr thomas received an msc in economics from the london school of economics and graduated magna cum laude with a babs in finance and economics from the wharton school from the university of pennsylvaniaread full background corporate headquarters one stamford plazastamford connecticut united statesphone fax  board members memberships presentlead directorcas medical systems inc education ba university of pennsylvania  the wharton schoolbs university of pennsylvania  the wharton schoolms the london school of economics and political science other affiliations warburg pincus llcanergen incorporatedceltrix pharmaceuticals inccoley pharmaceutical group incmenley  james incmedtronic xomed incneocrin companyoxford glycosciences plcscientific learning corporationthe medicines companyshire human genetic therapies incwright medical group nvgalil medical ltdosteobiologics inccas medical systems incgoldman sachs internationalwarburg pincus ventures lpthomas mcnerney  partners lpuniversity of pennsylvania  the wharton schoolwright medical technology incthe london school of economics and political scienceclarus therapeutics inctorax medical incsolstice neurosciences llcvertiflex incuniversata incthomas mcnerney  partners ii lpinnopharma inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact thomas mcnerney  partners please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft thomas mcnerney  partners ii lp  relationship science news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink thomas mcnerney  partners ii lp overview executives  employees paths recent transactions transaction advisors thomas mcnerney  partners ii lp overview industries private equity  venture capital investment services  portfolio management executives  employees alexendar henry zisson professional paths to thomas mcnerney  partners ii lp thomas mcnerney  partners ii lp you connections via relationship science thomas mcnerney  partners ii lp sync your contacts to see how you can connect with thomas mcnerney  partners ii lp start my free trial ➤ see more recent transactions details hidden auspex pharmaceuticals inc issued common stock transaction advisors companies ▾ legal advisor goodwin procter llp advised on auspex pharmaceuticals inc issued common stock people ▾ legal advisor arthur r mcgivern advised on auspex pharmaceuticals inc issued common stock youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ thomas mcnerney  partners  financial services firm stamford connecticut  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesthomas mcnerney  partners thomas mcnerney  partners overviewarticlesholdingsassetsservicesadvisorsleadershipfees share thomas mcnerney  partners overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description thomas mcnerney  partners is a ria based in stamford ct  james edward thomas is the majority owner of the firm and has been in this role with the firm since  information type ria head quarters stamford ct  of employees none total assets na website location  stamford plaza stamford ct   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on april   na total assets under management na total assets under advisement na accounts na estimated average account balance services firm services there is no services data available to display at this time firm client types there is no client type data to display at this time advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets james e thomas   pete h mcnerney   thomas mcnerney  partners ii llc   thomas mcnerney  partners llc   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership james edward thomas manager december   or more source sec fees there is no compensation data available to display at this time company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations brightscope  advisor pages  find a financial advisor or advisory firm getsearchtypedisplaynamesearchtype advisor funds firms k plans general search advisors advisory firms financial qa k plans funds search home    brightscope advisor pages    find a financial advisory firm advisor search firm search advisors by city find a financial advisory firm search firm name active firms only city state alabama alaska american samoa arizona arkansas california colorado connecticut delaware district of columbia florida georgia guam hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota northern marinara islands ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming firm service areas financial planning estate planning comprehensive financial planning retirement planning college planning charitable planning other financial planning tax planning insurance life insurance health insurance longterm care insurance annuities property  casualty insurance business insurance other insurance pension consulting k b  defined benefit other pension consulting portfolio management individuals andor small businesses investment companies businesses or institutional clients other portfolio management accounting  tax tax advice other tax legal legal planning legal advice other legal other publication of periodicals or newsletters security ratings or pricing services market timing services selection of other advisors educational seminarsworkshops see all service areas find filters financialplanningfindfirm compensation arrangements no preference fixed fees  hourly charges  performancebased fees  none  fee only  assets under mgmt no preference   k  m  m  m  m  m  m  b  b  avg account balance no preference   k  k  k  k  m  m  m  m  m  financial advisory firm search results  results merrill lynch pierce fenner  smith incorporated ny ny  advisors  aum  b wells fargo advisors llc st louis mo  advisors  aum  b jp morgan securities llc manhattan ny  advisors  aum  b morgan stanley smith barney llc harrison ny  advisors  aum  b lpl financial llc boston ma  advisors  aum  b edward d jones  co lp des peres mo  advisors  aum  b ameriprise financial services inc minneapolis mn  advisors  aum  b ubs financial services inc weehawken nj  advisors  aum  b northwestern mutual investment servicesllc milwaukee wi  advisors charles schwab  co inc south beach ca  advisors mml investors services llc pine point ma  advisors  aum  b goldman sachs  co ny ny  advisors  aum  b strategic advisers inc boston ma  advisors  aum  b citigroup global markets inc new york ny  advisors  aum  b raymond james  associates inc st petersburg fl  advisors  aum  b      company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations thomas mcnerney  partners  financial services firm stamford connecticut  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesthomas mcnerney  partners thomas mcnerney  partners overviewarticlesholdingsassetsservicesadvisorsleadershipfees share thomas mcnerney  partners overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description thomas mcnerney  partners is a ria based in stamford ct  james edward thomas is the majority owner of the firm and has been in this role with the firm since  information type ria head quarters stamford ct  of employees none total assets na website location  stamford plaza stamford ct   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on april   na total assets under management na total assets under advisement na accounts na estimated average account balance services firm services there is no services data available to display at this time firm client types there is no client type data to display at this time advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets james e thomas   pete h mcnerney   thomas mcnerney  partners ii llc   thomas mcnerney  partners llc   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership james edward thomas manager december   or more source sec fees there is no compensation data available to display at this time company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations